Tech Company Financing Transactions
Juniper Biosciences Funding Round
On 12/3/2025, Juniper Biosciences announced $40 million in Seed investment from NovaCapital and private investors.
Transaction Overview
Company Name
Announced On
12/3/2025
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Seed
Investors
NovaCapital (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
100 Somerset Corporate Boulevard, 2nd Floor
Bridgewater, NJ 08807
USA
Bridgewater, NJ 08807
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
At Juniper Biosciences, we are at the forefront of revolutionizing healthcare through innovative radiopharmaceuticals. Our mission is to improve patient access to novel therapeutic and diagnostic medicines and address unmet needs in cancer and other diseases, all while maintaining the most stringent standards of quality.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alex Agnoletto
Browse more venture capital transactions:
Prev: 12/3/2025: Junevity venture capital transaction
Next: 12/3/2025: Empathy Health Technologies venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs